A clinical study of efficacy and safety of the Carry Life UF system in continuous ambulatory peritoneal dialysis patients: protocol for a prospective, multicenter, randomized, crossover study
- Published on 04/09/2025
- Reading time: 8 min.
Wilkie Martin 1, de Leon Charlotte 2, Carlsson Ola 2, Hegbrant Jörgen 3, Heimbürger Olof 4
1 https://ror.org/03hwje554 Sheffield Kidney Institute, Sheffield Teaching Hospitals Sheffield UK
2 Triomed AB Lund Sweden
3 https://ror.org/012a77v79 Division of Nephrology, Department of Clinical Sciences Lund University Lund Sweden
4 https://ror.org/056d84691 Medical Unit Renal Medicine, Karolinska University Hospital, and CLINTEC Karolinska Institutet Stockholm Sweden
Abstract
Background Carry Life UF is a novel peritoneal dialysis (PD) technology for improved fluid management using steady concentration PD (SCPD). The Carry Life UF treatment starts with a manual peritoneal fill of 1.36% glucose PD fluid, followed by a 5-hour treatment where small amounts of glucose are continuously added to maintain a stable intraperitoneal glucose concentration. A recent in-center clinical study using the Carry Life UF system demonstrated higher ultrafiltration...
To continue reading this article in Full-Text...
Peer-Reviewed Journals A-Z
Search | Advanced search
Get the latest news in Nephrology
Receive our newsletter to stay up to date with the latest news in Nephrology
